Weiss Multi-Strategy Advisers’s Quest Diagnostics DGX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,384	Closed	-$467K	–	135
2023 Q4	$467K	Sell	3,384 -596	-15%	-$78.4K	0.01%	481
2023 Q3	$485K	Buy	+3,980	New	+$530K	0.01%	484
2022 Q2	–	Sell	-9,963	Closed	-$1.36M	–	691
2022 Q1	$1.36M	Buy	+9,963	New	+$1.39M	0.03%	457
2014 Q3	–	Sell	-11,050	Closed	-$649K	–	577
2014 Q2	$649K	Buy	11,050 +1,100	+11%	+$64.4K	0.01%	475
2014 Q1	$576K	Buy	9,950 +5,820	+141%	+$312K	0.01%	616
2013 Q4	$221K	Buy	+4,130	New	+$245K	﹤0.01%	887

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weiss Multi-Strategy Advisers's DGX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 3,384 shares — an estimated $467K sold.

Weiss Multi-Strategy Advisers first reported a position in DGX in Q4 2013 and held it in 6 quarters. The position peaked at $1.36M in Q1 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 3,384 Quest Diagnostics shares in Q1 2024, an estimated $467K.
Weiss Multi-Strategy Advisers first reported a position in Quest Diagnostics in Q4 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Quest Diagnostics position peaked at $1.36M in Q1 2022.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.